Project description
New technology for growing medical plants
An estimated 18 000 plants known to science are classified as medical plants. However, only 150 of them are industrially farmed. Nutraceutical, pharmaceutical and cosmetic industries obtain the biologically active elements from the plant roots. Nevertheless, production through cultivation or harvesting in the wild, especially for ginseng, do not meet market demands. The EU-funded Rhizomia project is developing an innovative hydroponic technology that enables rapid sustainable production methods. Rhizomia empowers biomass growth and advances active ingredient extraction. Today, the ginseng market is dominated by non-EU actors. Rhizomia aims to create a large-scale production technology that will allow the EU to reach up to 35 % of market share by 2030.
Fields of science
Programme(s)
Funding Scheme
SME-2 - SME instrument phase 2Coordinator
7800 Ath
Belgium
See on map